Advances and challenges in malaria vaccine development
Open accessThe DOI matches its Crossref record; 104 of the 104 references it cites were found in a registry or an index.
Abstract
Malaria caused by Plasmodium falciparum remains a major public health threat, especially among children and pregnant women in Africa. An effective malaria vaccine would be a valuable tool to reduce the disease burden and could contribute to elimination of malaria in some regions of the world. Current malaria vaccine candidates are directed against human and mosquito stages of the parasite life cycle, but thus far, relatively few proteins have been studied for potential vaccine development. The most advanced vaccine candidate, RTS,S, conferred partial protection against malaria in phase II clinical trials and is currently being evaluated in a phase III trial in Africa. New vaccine targets need to be identified to improve the chances of developing a highly effective malaria vaccine. A better understanding of the mechanisms of naturally acquired immunity to malaria may lead to insights for vaccine development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genome sequence of the human malaria parasite Plasmodium falciparum
Gardner, M. J., Hall, N., Fung, E., White, O., Berriman, M., Hyman, R. W., Carlton, J. M., Pain, A., Nelson, K. E., Bowman, S., et al. (2002) · Nature · doi:10.1038/nature01097 · Cited by 4,407
The global distribution of clinical episodes of Plasmodium falciparum malaria
Snow, R. W., Guerra, C. A., Noor, A. M., Myint, H. Y., & Hay, S. I. (2005) · Nature · doi:10.1038/nature03342 · Cited by 2,741
Gamma-Globulin and Acquired Immunity to Human Malaria
COHEN, S., McGREGOR, I. A., & CARRINGTON, S. (1961) · Nature · doi:10.1038/192733a0 · Cited by 1,393
A proteomic view of the Plasmodium falciparum life cycle
Florens, L., Washburn, M. P., Raine, J. D., Anthony, R. M., Grainger, M., Haynes, J. D., Moch, J. K., Muster, N., Sacci, J. B., Tabb, D. L., et al. (2002) · Nature · doi:10.1038/nature01107 · Cited by 1,308
Adherence of Plasmodium falciparum to Chondroitin Sulfate A in the Human Placenta
Fried, M., & Duffy, P. E. (1996) · Science · doi:10.1126/science.272.5267.1502 · Cited by 1,108
Invasion of Red Blood Cells by Malaria Parasites
Cowman, A. F., & Crabb, B. S. (2006) · Cell · doi:10.1016/j.cell.2006.02.006 · Cited by 943
Protective Immunity produced by the Injection of X-irradiated Sporozoites of Plasmodium berghei
NUSSENZWEIG, R. S., VANDERBERG, J., MOST, H., & ORTON, C. (1967) · Nature · doi:10.1038/216160a0 · Cited by 937
Immunity to malaria: more questions than answers
Langhorne, J., Ndungu, F. M., Sponaas, A.-M., & Marsh, K. (2008) · Nature Immunology · doi:10.1038/ni.f.205 · Cited by 878
Stoute, J. A., Slaoui, M., Heppner, D. G., Momin, P., Kester, K. E., Desmons, P., Wellde, B. T., Garçon, N., Krzych, U., Marchand, M., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199701093360202 · Cited by 870
Vivax Malaria: Neglected and Not Benign
Price, R. N., Tjitra, E., Guerra, C. A., Yeung, S., White, N. J., & Anstey, N. M. (2007) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2007.77.79 · Cited by 838
Research works printed but not linked: 23
- Pinzon-Charry, 2010, J Clin Invest., 120, 2967, 10.1172/JCI39222 · doi:10.1172/jci39222
- Carter, 1979, Bull World Health Organ., 57, 37
- Nussenzweig, 1986, Am J Trop Med Hyg., 35, 678, 10.4269/ajtmh.1986.35.678 · doi:10.4269/ajtmh.1986.35.678
- Walther, 2006, Infect Immun., 74, 2706, 10.1128/IAI.74.5.2706-2716.2006 · doi:10.1128/iai.74.5.2706-2716.2006
- 10.1016/j.vaccine.2004.08.020 · doi:10.1016/j.vaccine.2004.08.020
- Kubler-Kielb, 2010, Proc Natl Acad Sci U S A., 107, 1172, 10.1073/pnas.0913374107 · doi:10.1073/pnas.0913374107
- Clyde, 1990, Bull World Health Organ., 68, 9
- Celada, 1982, Clin Exp Immunol., 47, 635
- 10.1128/IAI.74.2.1412-1415.2006 · doi:10.1128/iai.74.2.1412-1415.2006
- 10.1128/AAC.49.10.4421-4422.2005 · DOI
- Sagara, 2009, Vaccine., 27, 3090, 10.1016/j.vaccine.2009.03.014 · DOI
- 10.1371/journal.pone.0007549 · doi:10.1371/journal.pone.0007549
- 10.1371/journal.pmed.0020344 · doi:10.1371/journal.pmed.0020344
- Horii, 2010, Parasitol Int., 59, 380, 10.1016/j.parint.2010.05.002 · doi:10.1016/j.parint.2010.05.002
- Malkin, 2008, Vaccine., 26, 6864, 10.1016/j.vaccine.2008.09.081 · DOI
- 10.1111/j.1365-3024.2009.01138.x · doi:10.1111/j.1365-3024.2009.01138.x
- Takala, 2009, Sci Transl Med., 1, 2ra5, 10.1126/scitranslmed.3000257 · DOI
- 10.1016/j.vaccine.2008.02.020 · doi:10.1016/j.vaccine.2008.02.020
- 10.1084/jem.160.3.935 · doi:10.1084/jem.160.3.935
- 10.1084/jem.180.1.297 · doi:10.1084/jem.180.1.297
- Guttinger, 1988, EMBO J., 7, 2555, 10.1002/j.1460-2075.1988.tb03104.x · doi:10.1002/j.1460-2075.1988.tb03104.x
- 10.1038/334258a0 · doi:10.1038/334258a0
- 10.1371/journal.pone.0005254 · doi:10.1371/journal.pone.0005254
Cited by
Functional Profiling of a Plasmodium Genome Reveals an Abundance of Essential Genes
Bushell, E., Gomes, A. R., Sanderson, T., Anar, B., Girling, G., Herd, C., Metcalf, T., Modrzynska, K., Schwach, F., Martin, R. E., et al. (2017) · Cell · doi:10.1016/j.cell.2017.06.030 · Cited by 559
Malaria: The Past and the Present
Talapko, J., Škrlec, I., Alebić, T., Jukić, M., & Včev, A. (2019) · Microorganisms · doi:10.3390/microorganisms7060179 · Cited by 395
Crompton, P. D., Moebius, J., Portugal, S., Waisberg, M., Hart, G., Garver, L. S., Miller, L. H., Barillas-Mury, C., & Pierce, S. K. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120220 · Cited by 317
Self-citationTakem, E. N., & D'Alessandro, U. (2013) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2013.010 · Cited by 185
Metadata
- Authors
- Crompton, P. D., Pierce, S. K., & Miller, L. H.
- Venue
- Journal of Clinical Investigation
- Published
- 2010-12-01
- Volume
- 120
- Issue
- 12
- Pages
- 4168-4178
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2131277865
- Cited by
- 269
- References
- 104
- FWCI
- 28.92
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.